| Cenerimod | A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus | Phase 3 | Active not recruiting | 451 | Dec 31, 2026 |
| Sucralfate | Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation | Phase 2 | Completed | 142 | Aug 26, 2026 |
| Varenicline | Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2 | Phase 2 | Terminated | 3 | Aug 5, 2026 |
| Everolimus 0.5 MG once per day | Everolimus Aging Study | Phase 2 | Completed | 106 | Jun 30, 2026 |
| Allopurinol | Allopurinol Improves Heart Function in African Americans With Resistant Hypertension | Phase 2 | Completed | 40 | Apr 30, 2026 |
| Use of Linaclotide as a single agent Colonoscopy prep | Linaclotide for Colonoscopy Bowel Prep | Phase 2 | Terminated | 4 | Apr 7, 2026 |
| Roflumilast | Roflumilast or Azithromycin to Prevent COPD Exacerbations Trial | Phase 3 | Completed | 1,032 | Mar 1, 2026 |
| Eszopiclone | Do Endotypes Predict Response and Sequelae in OSA Patients | Phase 2 | Completed | 233 | Feb 11, 2026 |
| Paclitaxel | Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy | Phase 2 | Completed | 50 | Feb 10, 2026 |
| Varenicline | Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment | Phase 2 | Completed | 126 | Jan 2, 2026 |
| Tamoxifen 10 mg Tablet | Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion | Phase 2 | Completed | 110 | Dec 31, 2025 |
| Febuxostat Tablets | Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic Patients | Phase 2 | Completed | 60 | Dec 30, 2025 |
| Midodrine | Automated Abdominal Binder for Orthostatic Hypotension | Phase 2 | Completed | 28 | Nov 19, 2025 |
| Mirtazapine | Trial of Mirtazapine for Depression in IBD | Phase 2 | Completed | 76 | Oct 3, 2025 |
| Mesalamine | Fenofibrate in Ulcerative Colitis | Phase 3 | Completed | 60 | Sep 20, 2025 |
| Inhaled budesonide and formoterol | ARrest RESpiraTory Failure From PNEUMONIA | Phase 3 | Terminated · results | 465 | Jul 22, 2025 |
| Ticagrelor 90mg | Ticagrelor Monotherapy After Stenting | Phase 2 | Completed | 200 | Jun 26, 2025 |
| Lenalidomide 10 mg | MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients | Phase 2 | Completed | 15 | May 31, 2025 |
| Dexmedetomidine | Dexmedetomidine in Postoperative Analgesia | Phase 3 | Completed | 100 | May 15, 2025 |
| Dolutegravir (DTG) 50 mg orally BID (~12 hours apart) plus TDF/3TC | Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis | Phase 2 | Completed · results | 30 | May 7, 2025 |
| Varenicline | Combining Varenicline and Guanfacine for Smoking Cessation | Phase 2 | Completed · results | 167 | Apr 30, 2025 |
| Fluvoxamine | Fluvoxamine for Long COVID-19 | Phase 3 | Completed · results | 191 | Mar 15, 2025 |
| Vancomycin | Vancomycin for Primary Sclerosing Cholangitis | Phase 3 | Terminated · results | 102 | Mar 3, 2025 |
| Dexmedetomidine | Dexmedetomidinine in the Prevention of Postoperative Delirium in the Intensive Care Unit After Cardiac Surgery | Phase 3 | Completed | 300 | Feb 1, 2025 |
| norelgestromin/ethinyl estradiol weekly patch | Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles | Phase 3 | Completed · results | 1,320 | Jan 15, 2025 |
| Revefenacin Inhalation Solution [Yupelri] | Revefenacin in Acute Respiratory Insufficiency in COPD | Phase 2 | Completed · results | 21 | Jan 1, 2025 |
| dolutegravir | ANRS 12372 MODERATO Study | Phase 3 | Completed | 480 | Dec 30, 2024 |
| Mesalamine | Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis | Phase 3 | Completed | 50 | Dec 20, 2024 |
| Pomalidomide | Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection | Phase 2 | Completed · results | 26 | Nov 29, 2024 |
| Atorvastatin | The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients | Phase 2 | Completed | 44 | Oct 20, 2024 |
| Lenalidomide | Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma | Phase 2 | Completed · results | 40 | Aug 22, 2024 |
| Sorafenib | Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC | Phase 3 | Completed | 326 | May 31, 2024 |
| Mesalamine | Repurposing Fenofibrate in Modulating AMPK/NLRP3 Inflammasome in Patients With Ulcerative Colitis | Phase 2 | Completed | 70 | Apr 20, 2024 |
| Allopurinol Tablet | Allopurinol and Pathogenesis of Cirrhosis | Phase 2 | Completed | 110 | Mar 1, 2024 |
| Atorvastatin 80mg | Atorvastatin in Patients With Ulcerative Colitis | Phase 2 | Completed | 50 | Mar 1, 2024 |
| roflumilast cream 0.3% | Bioequivalence Study of Two Treatments for the Treatment of Plaque Psoriasis | Phase 3 | Completed · results | 416 | Aug 8, 2023 |
| Ticagrelor | The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention | Phase 3 | Completed | 40 | Jul 6, 2023 |
| prazosin hydrochloride | Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin | Phase 2 | Completed · results | 89 | May 31, 2023 |
| CAM2029 (octreotide subcutaneous depot) | A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly | Phase 3 | Completed · results | 72 | May 2, 2023 |
| Ticagrelor 90mg | The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions | Phase 3 | Terminated · results | 31 | Mar 28, 2023 |